--°C
Loading...
Listen to Article
2 min read
80%

The UK medical authorities also cited an exploratory analysis in which it was discovered that the dose produced a good immune response against the two most prevalent Omicron sub-variants at the time, BA.4 and BA.5.

Digital Desk: The Covid variant, Omicron's vaccination has been approved in Britain for the first time. According to Reuters, the UK pharmaceutical authority (MHRA) has authorised Moderna's "bivalent" vaccination as a booster shot for adults.

Clinical trial data that indicated the booster elicited "a significant immune response" against both Omicron (BA.1) and the original 2020 virus, according to the EPA, served as the foundation for its conclusion.

The UK medical authorities also cited an exploratory analysis in which it was discovered that the dose produced a good immune response against the two most prevalent Omicron sub-variants at the time, BA.4 and BA.5.


FOLLOW US F
POPULAR
FEATURE
TRENDY
Healing Through Harmony: The Mental Health Benefits of Music Therapy
ASMITA City Badminton League Set to Begin in Guwahati from 20th August
Lightning, Downpour, and Waterlogging: Guwahati Wakes Up to Stormy Morning
9 Unique Types of Water You Can Actually Drink – and What Makes Each Special
Happy Friendship Day 2025: Celebrating the Bonds That Unite Us
Kickstart Your Day with Ghee Water: A Time-Tested Wellness Ritual